Axion Meditech And Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 M
as on 04-12-2024
- Revenue -36.95%
(FY 2022)
- Profit -70.95%
(FY 2022)
- Ebitda -188.92%
(FY 2022)
- Net Worth 18.29%
(FY 2022)
- Total Assets 10.40%
(FY 2022)
About Axion Meditech And Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.50 M.
Pranavkumar Dhumad and Bhurubhai Dhummad serve as directors at the Company.
- CIN/LLPIN
U74999GJ2018PTC103058
- Company No.
103058
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jun 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Axion Meditech And Life Science Private Limited offer?
Axion Meditech And Life Science Private Limited offers a wide range of products and services, including Disposable & Other Optical Lenses, Intraocular Lenses.
Who are the key members and board of directors at Axion Meditech And Life Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranavkumar Dhumad  | Director | 23-Aug-2022 | Current |
| Bhurubhai Dhummad | Director | 28-Jun-2018 | Current |
Financial Performance of Axion Meditech And Life Science.
Axion Meditech And Life Science Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 36.95% decrease. The company also saw a substantial fall in profitability, with a 70.95% decrease in profit. The company's net worth Soared by an impressive increase of 18.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Axion Meditech And Life Science?
Unlock access to Axion Meditech And Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 27 Aug 2019 | ₹4.50 M | Open |
How Many Employees Work at Axion Meditech And Life Science?
Unlock and access historical data on people associated with Axion Meditech And Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Axion Meditech And Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axion Meditech And Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
